Timing of epidermal growth factor receptor tyrosine kinase inhibitor therapy in patients with lung cancer with EGFR mutations

J Clin Oncol. 2012 Sep 20;30(27):3330-6. doi: 10.1200/JCO.2012.43.1858. Epub 2012 Jul 2.
No abstract available

Publication types

  • Case Reports
  • Clinical Conference

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / pathology
  • Antineoplastic Combined Chemotherapy Protocols
  • Drug Administration Schedule
  • Drug Resistance, Neoplasm
  • ErbB Receptors / antagonists & inhibitors
  • ErbB Receptors / genetics
  • ErbB Receptors / metabolism*
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Middle Aged
  • Protein Kinase Inhibitors / administration & dosage*

Substances

  • Protein Kinase Inhibitors
  • ErbB Receptors